The U.K.'s National Health Service has partnered with Google to have the company apply its artificial intelligence efforts, known as DeepMind, to the healthcare data of the 1.6 million patients treated at three London hospitals each year.
Fitbit is lending its wearable health trackers to the Dana-Farber Cancer Institute for a study on weight loss in breast cancer patients. The partnership could give the company more clout as it pursues its med tech ambitions.
German aesthetic player Merz has invested in recently announced company Cytrellis Biosystems. The Boston-based startup is developing aesthetic medical devices to remove sagging skin without surgery or scarring.
Stratasys and the Jacobs Institute are partnering to create an R&D center aimed at using 3-D printing to test and develop new medical devices. The company, which is based in Minneapolis and Israel, is aiming at making further inroads into medical applications, which haven't been a major market for 3-D printers yet.
The Goldman Sachs-backed startup Imaging Advantage, which reportedly tapped into up to $250 million in debt in January 2015, has partnered with the Massachusetts Institute of Technology as well as Harvard Medical School and Massachusetts General Hospital to develop an artificial intelligence engine known as Singularity Healthcare.
Novartis is working to execute on its turnaround plan for its Alcon vision business. But for now, sales are still on the decline. In the first quarter, Alcon net sales fell 7% from $1.4 billion. The company said it expects the unit to return to sales growth during the second half of this year--and that it ultimately expects it to have low-single-digit organic growth.
Beleaguered Novartis vision business Alcon is looking for a turnaround. It's been placing some bets on innovation to help it do so in the long term. Now, the vision care specialist has partnered with--and invested in--fluid intraocular lens implant company PowerVision. Alcon also gained an option to acquire the Belmont, CA-based startup as part of the deal.
Propeller Health knows that M&A is key to staying ahead in a competitive smart inhaler environment, and the company recently added another deal to its slate. Propeller is teaming up with remote patient monitoring outfit AMC Health to roll out a program aimed at improving drug adherence for individuals with chronic obstructive pulmonary disease (COPD).
The life sciences isn't a huge business for 3-D printing player Materialise--but it's working to change that. Its latest move is a deal with Canon Lifecare Solutions, a subsidiary of Canon Global, which will market Materialise 3-D printing to hospitals in Japan.
Seoul-based Dong-A ST has signed a new licensing deal with Tobira Therapeutics that will see it gain access to research and sell the California company's fatty liver disease treatment with its new diabetes drug in its native Korea.